DA 3003-2

• Description:

  DA 3003-2 is a potent and selectively Cdc25 inhibitor. DA 3003-2 shows antiproliferative activity. DA 3003-2 induces cell cycle arrest at the G2/M phase and increases the expression of P-tyr15 Cdc2. DA 3003-2 has the potential for the research of prostate cancer[1].

• Product Name Alternative:

  NSC663285

• UNSPSC:

  12352005

• Target:

  Phosphatase

• Type:

  Reference compound

• Related Pathways:

  Metabolic Enzyme/Protease

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/da-3003-2.html

• Purity:

  98.36

• Solubility:

  DMSO : 150 mg/mL (ultrasonic)

• Smiles:

  O=C(C1=C(C2=O)N=CC=C1)C(NCCN3CCOCC3)=C2Cl

• Molecular Formula:

  C15H16ClN3O3

• Molecular Weight:

  321.76

• References & Citations:

  [1]Nemoto K. G2/M accumulation in prostate cancer cell line PC-3 is induced by Cdc25 inhibitor 7-chloro-6- (2-morpholin-4-ylethylamino) quinoline-5, 8-dione (DA 3003-2) . Exp Ther Med. 2010 Jul;1 (4) :647-650.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  4°C (Powder, sealed storage, away from moisture and light)

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  [383907-47-9]